November 14, 2011

APPLE SIRI VOICE RECOGNITION TRUMPS ANDROID VOICE

In a small study at The Arora Report, accuracy of Apple (AAPL) Siri voice recognition trumped Google (GOOG) Android voice recognition.

The study involved reading a page of text by five different persons to Apple Siri and three android devices in a room with moderate conversational noise.

Siri showed only 96% accuracy which is less than what Apple enthusiasts claim.

Android fared even worse with only 93% accuracy.

The study was repeated with no material noise. Siri showed accuracy of 98%, Android showed accuracy of 97%.

The accuracy needs to approach 100% for voice recognition to be truly useful. The results showed that in real life, without training, voice recognition accuracy is lower than widely believed.… Please click here or the title below to read more.

November 14, 2011

CRAY (CRAY): BIG SUPER COMPUTER ORDER

Cray (CRAY) stock is trading strongly higher after it was announced that University of Illinois’ National Center for Supercomputing Applications has struck a $188 million multi-year deal with Cray.

Cray will provide XE6 and XK6 models. These computers will incorporate Opteron CPUs from Advanced Micro Devices (AMD) and Kapler GPU from Nvidia (NVDA). Historically, Cray moves up on big announcements and then drifts down unless there is a short squeeze.

… Please click here or the title below to read more.

November 14, 2011

IBM (IBM) PURCHASE BY BUFFETT

IBM (IBM) can now count Warren Buffett as owner of over 5% of the stock. Buffett has built his $10.7 billion stake in IBM over the last two quarters. This is Buffett’s first big technology purchase.

Investors may want to observe caution in following Buffett into IBM as Buffett stated that he is done with his purchases and his purchases were at an average cost of about $170. Now IBM is trading around $190.… Please click here or the title below to read more.

November 14, 2011

AMAG PHARMACEUTICALS (AMAG): DRUG SHOWS PROMISE

AMAG Pharmaceuticals (AMAG) announced a study of its drug Feraheme (ferumoxytol) that makes it an acquisition candidate. New study from a head-to-head trial comparing Feraheme Injection for intravenous use to iron sucrose in patients with iron deficiency anemia and chronic kidney disease is positive for AMAG Pharmaceuticals. The data was presented in the late-breaking clinical trials poster session at the American Society of Nephrology.

If and when six screens of the ZYX Change Method are satisfied, we will issue a buy signal on the Real Time Feed of the ZYX Buy Change Alert.… Please click here or the title below to read more.

November 14, 2011